THC Biomed Intl Past Earnings Performance

Past criteria checks 0/6

THC Biomed Intl's earnings have been declining at an average annual rate of -19.2%, while the Pharmaceuticals industry saw earnings growing at 10.4% annually. Revenues have been declining at an average rate of 9.9% per year.

Key information

-19.2%

Earnings growth rate

-20.1%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate-9.9%
Return on equity-78.1%
Net Margin-164.8%
Last Earnings Update30 Apr 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How THC Biomed Intl makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:TFHD Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 232-420
31 Jan 232-320
31 Oct 222-320
31 Jul 222-320
30 Apr 222-320
31 Jan 223-420
31 Oct 213-620
31 Jul 213-620
30 Apr 213-620
31 Jan 212-520
31 Oct 203-220
31 Jul 203020
30 Apr 203-430
31 Jan 203-840
31 Oct 192-1350
31 Jul 191-1360
30 Apr 191-1250
31 Jan 191-740
31 Oct 181-1230
31 Jul 181-1230
30 Apr 181-1030
31 Jan 181-1120
31 Oct 170-120
31 Jul 170-110
30 Apr 170010
31 Jan 170110
31 Oct 160110
31 Jul 160-110
30 Apr 160-220
31 Jan 160-220
31 Oct 150-320
31 Jul 150-320
30 Apr 150-210
31 Jan 150-200
31 Oct 140000

Quality Earnings: TFHD is currently unprofitable.

Growing Profit Margin: TFHD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if TFHD's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare TFHD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TFHD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.7%).


Return on Equity

High ROE: TFHD has a negative Return on Equity (-78.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies